Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 12

1.

Allogeneic Transplantation in First Remission Improves Outcomes Irrespective of FLT3-ITD Allelic Ratio in FLT3-ITD-Positive Acute Myelogenous Leukemia.

Oran B, Cortes J, Beitinjaneh A, Chen HC, de Lima M, Patel K, Ravandi F, Wang X, Brandt M, Andersson BS, Ciurea S, Santos FP, de Padua Silva L, Shpall EJ, Champlin RE, Kantarjian H, Borthakur G.

Biol Blood Marrow Transplant. 2016 Jul;22(7):1218-1226. doi: 10.1016/j.bbmt.2016.03.027. Epub 2016 Apr 4.

2.

Randomized phase II trial comparing two dose levels of thymoglobulin in patients undergoing unrelated donor hematopoietic cell transplant.

Bashir Q, Munsell MF, Giralt S, de Padua Silva L, Sharma M, Couriel D, Chiattone A, Popat U, Qazilbash MH, Fernandez-Vina M, Champlin RE, de Lima MJ.

Leuk Lymphoma. 2012 May;53(5):915-9. doi: 10.3109/10428194.2011.634039. Epub 2011 Dec 5.

3.

Myeloablative reduced-toxicity i.v. busulfan-fludarabine and allogeneic hematopoietic stem cell transplant for patients with acute myeloid leukemia or myelodysplastic syndrome in the sixth through eighth decades of life.

Alatrash G, de Lima M, Hamerschlak N, Pelosini M, Wang X, Xiao L, Kerbauy F, Chiattone A, Rondon G, Qazilbash MH, Giralt SA, de Padua Silva L, Hosing C, Kebriaei P, Zhang W, Nieto Y, Saliba RM, Champlin RE, Andersson BS.

Biol Blood Marrow Transplant. 2011 Oct;17(10):1490-6. doi: 10.1016/j.bbmt.2011.02.007. Epub 2011 Feb 18.

4.

Unrelated donor transplantation for acute myelogenous leukemia in first remission.

Bashir Q, Andersson BS, Fernandez-Vina M, de Padua Silva L, Giralt S, Chiattone A, Wei W, Sharma M, Anderlini P, Shpall EJ, Popat U, Rodrigues M, Champlin RE, de Lima M.

Biol Blood Marrow Transplant. 2011 Jul;17(7):1067-71. doi: 10.1016/j.bbmt.2010.11.012. Epub 2010 Nov 16.

5.

Maintenance therapy with low-dose azacitidine after allogeneic hematopoietic stem cell transplantation for recurrent acute myelogenous leukemia or myelodysplastic syndrome: a dose and schedule finding study.

de Lima M, Giralt S, Thall PF, de Padua Silva L, Jones RB, Komanduri K, Braun TM, Nguyen HQ, Champlin R, Garcia-Manero G.

Cancer. 2010 Dec 1;116(23):5420-31. doi: 10.1002/cncr.25500. Epub 2010 Jul 29.

6.

Resolved hepatitis B virus infection is not associated with worse outcome after allogeneic hematopoietic stem cell transplantation.

Ramos CA, Saliba RM, de Pádua Silva L, Khorshid O, Shpall EJ, Giralt S, Patah PA, Hosing CM, Popat UR, Rondon G, Nieto Y, Champlin RE, de Lima M.

Biol Blood Marrow Transplant. 2010 May;16(5):686-94. doi: 10.1016/j.bbmt.2009.12.532. Epub 2010 Jan 6. Erratum in: Biol Blood Marrow Transplant. 2011 May;17(5):770.

7.

Moderate renal function impairment does not affect outcomes of reduced-intensity conditioning with fludarabine and melphalan for allogeneic hematopoietic stem cell transplantation.

de Souza JA, Saliba RM, Patah P, Rondon G, Ribeiro R, de Padua Silva L, Qazilbash MH, Hosing C, Popat U, Efebera Y, Champlin RE, de Lima M.

Biol Blood Marrow Transplant. 2009 Sep;15(9):1094-9. doi: 10.1016/j.bbmt.2009.05.006.

8.

Donor-recipient mismatches in MHC class I chain-related gene A in unrelated donor transplantation lead to increased incidence of acute graft-versus-host disease.

Parmar S, Del Lima M, Zou Y, Patah PA, Liu P, Cano P, Rondon G, Pesoa S, de Padua Silva L, Qazilbash MH, Hosing C, Popat U, Kebriaei P, Shpall EJ, Giralt S, Champlin RE, Stastny P, Fernandez-Vina M.

Blood. 2009 Oct 1;114(14):2884-7. doi: 10.1182/blood-2009-05-223172. Epub 2009 Aug 4.

9.

Feasibility of allo-SCT after hypomethylating therapy with decitabine for myelodysplastic syndrome.

De Padua Silva L, de Lima M, Kantarjian H, Faderl S, Kebriaei P, Giralt S, Davisson J, Garcia-Manero G, Champlin R, Issa JP, Ravandi F.

Bone Marrow Transplant. 2009 Jun;43(11):839-43. doi: 10.1038/bmt.2008.400. Epub 2009 Jan 19.

PMID:
19151791
10.

Novel preparative regimens in hematopoietic stem cell transplantation.

Lekakis L, de Padua Silva L, de Lima M.

Curr Pharm Des. 2008;14(20):1923-35. Review.

PMID:
18691104
11.

Rituximab for passenger lymphocyte syndrome associated with allogeneic SCT.

Lee HJ, Gulbis A, De Padua Silva L, Hosing C, Khouri I, de Lima M, Champlin RE, Ciurea SO.

Bone Marrow Transplant. 2008 Jul;42(1):67-9. doi: 10.1038/bmt.2008.79. Epub 2008 Mar 17. Review. No abstract available.

PMID:
18347568
12.

High-dose chemotherapy and autologous hematopoietic progenitor cell transplantation for non-Hodgkin's lymphoma in patients >65 years of age.

Hosing C, Saliba RM, Okoroji GJ, Popat U, Couriel D, Ali T, De Padua Silva L, Kebriaei P, Alousi A, De Lima M, Qazilbash M, Anderlini P, Giralt S, Champlin RE, Khouri I.

Ann Oncol. 2008 Jun;19(6):1166-71. doi: 10.1093/annonc/mdm608. Epub 2008 Feb 13.

Supplemental Content

Loading ...
Support Center